These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 18427620)
1. Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Dana R Trans Am Ophthalmol Soc; 2007; 105():330-43. PubMed ID: 18427620 [TBL] [Abstract][Full Text] [Related]
2. Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. Qian Y; Dekaris I; Yamagami S; Dana MR Arch Ophthalmol; 2000 Dec; 118(12):1666-71. PubMed ID: 11115261 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist eye drops promoting high-risk corneal allografts survival in rats. Jie Y; Zhang WH; Pan ZQ; Wu YY; Wang Y Chin Med J (Engl); 2004 May; 117(5):711-6. PubMed ID: 15161539 [TBL] [Abstract][Full Text] [Related]
8. SEB combined with IL-1ra could prolong the survival of the rat allografts in high-risk corneal transplantation. Jie Y; Pan Z; Chen Y; Wei Y; Zhang W; Xu L; Wu Y; Peng H Transplant Proc; 2004 Dec; 36(10):3267-71. PubMed ID: 15686743 [TBL] [Abstract][Full Text] [Related]
9. Topical modulation of interleukin-1 activity in corneal neovascularization. Dana MR; Zhu SN; Yamada J Cornea; 1998 Jul; 17(4):403-9. PubMed ID: 9676913 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. Dana MR; Dai R; Zhu S; Yamada J; Streilein JW Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547 [TBL] [Abstract][Full Text] [Related]
11. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626 [TBL] [Abstract][Full Text] [Related]
12. The experimental treatment of corneal graft rejection with the interleukin-1 receptor antagonist (IL-1ra) gene. Yuan J; Liu Y; Huang W; Zhou S; Ling S; Chen J PLoS One; 2013; 8(5):e60714. PubMed ID: 23723965 [TBL] [Abstract][Full Text] [Related]
13. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea. Kamiya K; Wang M; Uchida S; Amano S; Oshika T; Sakuragawa N; Hori J Exp Eye Res; 2005 May; 80(5):671-9. PubMed ID: 15862174 [TBL] [Abstract][Full Text] [Related]
14. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Yamada J; Dana MR; Sotozono C; Kinoshita S Exp Eye Res; 2003 Feb; 76(2):161-7. PubMed ID: 12565803 [TBL] [Abstract][Full Text] [Related]
15. [Effects of IL-1 receptor antagonist on the level of cytokine in the rat corneal grafts and aqueous humor after corneal transplantation]. Zhang WH; Zhai CB; Pan ZQ; Wu YY Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):587-91. PubMed ID: 14766071 [TBL] [Abstract][Full Text] [Related]
16. [An experimental study on subconjunctival interleukin-1 receptor antagonist for promotion of corneal transplant survival]. Zhai C; Zhang W; Zou L; Pan Z; Li N; Wu Y; Lu L; Zhang S; Ma D Zhonghua Yan Ke Za Zhi; 2001 Jul; 37(4):270-2. PubMed ID: 11864435 [TBL] [Abstract][Full Text] [Related]
17. Effect of locally administered anti-CD154 (CD40 ligand) monoclonal antibody on survival of allogeneic corneal transplants. Qian Y; Dana MR Cornea; 2002 Aug; 21(6):592-7. PubMed ID: 12131037 [TBL] [Abstract][Full Text] [Related]
18. [Clinical study on continuous plasma filtration absorption treatment for burn sepsis]. Meng A; Ren Y; Yang L; He L; Zeng S; Liu Q Zhonghua Shao Shang Za Zhi; 2014 Aug; 30(4):310-4. PubMed ID: 25429809 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Coxon A; Bolon B; Estrada J; Kaufman S; Scully S; Rattan A; Duryea D; Hu YL; Rex K; Pacheco E; Van G; Zack D; Feige U Arthritis Rheum; 2002 Oct; 46(10):2604-12. PubMed ID: 12384918 [TBL] [Abstract][Full Text] [Related]
20. Cytokine expression during orthotopic corneal allograft rejection in mice. Sano Y; Osawa H; Sotozono C; Kinoshita S Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1953-7. PubMed ID: 9727419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]